| Dr Matthew Robert Paszek, MD | |
|
180 Foy Dr, Rocky Mount, NC 27804-2417 | |
| (252) 443-3136 | |
| (252) 443-3847 |
| Full Name | Dr Matthew Robert Paszek |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 18 Years |
| Location | 180 Foy Dr, Rocky Mount, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346403870 | NPI | - | NPPES |
| 201100007 | Other | NC | NC LICENSE |
| R1326 | Other | KY | KY RESIDENT LISCENCE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 201100007 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rex Hospital | Raleigh, NC | Hospital |
| Nash General Hospital | Rocky mount, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unc Physicians Network | 5496940546 | 709 |
News Archive
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients.
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology.
A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.
› Verified 8 days ago
| Entity Name | Unc Physicians Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750704367 PECOS PAC ID: 5496940546 Enrollment ID: O20101115000646 |
News Archive
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients.
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology.
A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Robert Paszek, MD 2000 Perimeter Park Dr Ste 200, Morrisville, NC 27560-8442 Ph: () - | Dr Matthew Robert Paszek, MD 180 Foy Dr, Rocky Mount, NC 27804-2417 Ph: (252) 443-3136 |
News Archive
The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients.
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. These findings were recently published by Yale School of Medicine researchers in the Journal of the American College of Cardiology.
A new study has been published in Science Advances that exploits proteomics datasets to develop an agnostic network for SARS-CoV-2–induced pathways, thereby unveiling novel targets and potential repurposing strategies.
› Verified 8 days ago
Dr. Joseph Durwood Whisnant, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 180 Foy Dr, Rocky Mount, NC 27804 Phone: 252-443-3136 Fax: 252-443-3847 | |
Dr. Gordon L Mathes, MD Urology Medicare: Medicare Enrolled Practice Location: 180 Foy Dr, Rocky Mount, NC 27804 Phone: 252-443-3136 Fax: 252-443-3847 | |
Dr. Frederick A Frohbose, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 180 Foy Dr, Rocky Mount, NC 27804 Phone: 252-443-3136 Fax: 252-443-3847 |